https://childrenshealthdefense.org/wp-content/uploads/2021-08-26-Letter-to-FDA-re-Comirnaty.pdf

#Comirnaty #Pfizer #Vaccine #LegallyDistinct #RonJohnson #Letter #FDA #2021-09

1. Why didn’t the FDA grant full licensure for the Pfizer-BioNTech vaccine that is in use and available in the U.S.?
2. How are the Comirnaty and #Pfizer-BioNTech #COVID-19 vaccines “legally distinct” and what are the “certain differences”?
3. There is no doubt that the FDA’s action will lead to more vaccine #mandates and increased pressure on those currently choosing not to get vaccinated. Your letter to Pfizer suggests that “there is not sufficient approved vaccine available for distribution.” Is there sufficient supply in the U.S. of the Comirnaty vaccine to ensure that those being #vaccinated under mandates will be receiving the FDA-approved version? Or is it more likely (or certain) that they will be vaccinated using the vaccine administered under the reissued #EUA?